000021501 001__ 21501
000021501 005__ 20240712084608.0
000021501 0247_ $$2pmid$$apmid:17765523
000021501 0247_ $$2DOI$$a10.1007/s10934-012-9589-7
000021501 0247_ $$2WOS$$aWOS:000312933400022
000021501 0247_ $$2altmetric$$aaltmetric:693065
000021501 037__ $$aPreJuSER-21501
000021501 041__ $$aeng
000021501 082__ $$a670
000021501 1001_ $$0P:(DE-HGF)0$$aKaufhold, S.$$b0
000021501 245__ $$aDensity and porosity of bentonites
000021501 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V$$c2013
000021501 300__ $$a191-208
000021501 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000021501 3367_ $$2DataCite$$aOutput Types/Journal article
000021501 3367_ $$00$$2EndNote$$aJournal Article
000021501 3367_ $$2BibTeX$$aARTICLE
000021501 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000021501 3367_ $$2DRIVER$$aarticle
000021501 440_0 $$03724$$aJournal of Porous Materials$$v20$$x1380-2224
000021501 500__ $$3POF3_Assignment on 2016-02-29
000021501 500__ $$aRecord converted from VDB: 12.11.2012
000021501 520__ $$aChronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide, and accurate estimates of the prevalence of this disease are needed to anticipate the future burden of COPD, target key risk factors, and plan for providing COPD-related health services. We aimed to measure the prevalence of COPD and its risk factors and investigate variation across countries by age, sex, and smoking status.Participants from 12 sites (n=9425) completed postbronchodilator spirometry testing plus questionnaires about respiratory symptoms, health status, and exposure to COPD risk factors. COPD prevalence estimates based on the Global Initiative for Chronic Obstructive Lung Disease staging criteria were adjusted for the target population. Logistic regression was used to estimate adjusted odds ratios (ORs) for COPD associated with 10-year age increments and 10-pack-year (defined as the number of cigarettes smoked per day divided by 20 and multiplied by the number of years that the participant smoked) increments. Meta-analyses provided pooled estimates for these risk factors.The prevalence of stage II or higher COPD was 10.1% (SE 4.8) overall, 11.8% (7.9) for men, and 8.5% (5.8) for women. The ORs for 10-year age increments were much the same across sites and for women and men. The overall pooled estimate was 1.94 (95% CI 1.80-2.10) per 10-year increment. Site-specific pack-year ORs varied significantly in women (pooled OR=1.28, 95% CI 1.15-1.42, p=0.012), but not in men (1.16, 1.12-1.21, p=0.743).This worldwide study showed higher levels and more advanced staging of spirometrically confirmed COPD than have typically been reported. However, although age and smoking are strong contributors to COPD, they do not fully explain variations in disease prevalence-other factors also seem to be important. Although smoking cessation is becoming an increasingly urgent objective for an ageing worldwide population, a better understanding of other factors that contribute to COPD is crucial to assist local public-health officials in developing the best possible primary and secondary prevention policies for their regions.
000021501 536__ $$0G:(DE-Juel1)FUEK404$$2G:(DE-HGF)$$aNukleare Sicherheitsforschung$$cP14$$x0
000021501 588__ $$aDataset connected to Pubmed
000021501 650_2 $$2MeSH$$aAdult
000021501 650_2 $$2MeSH$$aAge Distribution
000021501 650_2 $$2MeSH$$aAged
000021501 650_2 $$2MeSH$$aFemale
000021501 650_2 $$2MeSH$$aHumans
000021501 650_2 $$2MeSH$$aLogistic Models
000021501 650_2 $$2MeSH$$aMale
000021501 650_2 $$2MeSH$$aMiddle Aged
000021501 650_2 $$2MeSH$$aMulticenter Studies as Topic
000021501 650_2 $$2MeSH$$aPopulation Surveillance: methods
000021501 650_2 $$2MeSH$$aPrevalence
000021501 650_2 $$2MeSH$$aPulmonary Disease, Chronic Obstructive: epidemiology
000021501 650_2 $$2MeSH$$aPulmonary Disease, Chronic Obstructive: etiology
000021501 650_2 $$2MeSH$$aQuestionnaires
000021501 650_2 $$2MeSH$$aRisk Factors
000021501 650_2 $$2MeSH$$aSex Distribution
000021501 650_2 $$2MeSH$$aSmoking: adverse effects
000021501 650_2 $$2MeSH$$aSmoking: epidemiology
000021501 7001_ $$0P:(DE-HGF)0$$aPlötze, M.$$b1
000021501 7001_ $$0P:(DE-Juel1)130364$$aKlinkenberg, M.$$b2$$uFZJ
000021501 7001_ $$0P:(DE-HGF)0$$aDohrmann, R.$$b3
000021501 7001_ $$0P:(DE-HGF)0$$aSiegesmund, S.$$b4
000021501 773__ $$0PERI:(DE-600)2007476-1$$a10.1007/s10934-012-9589-7$$p191-208$$tJournal of porous materials$$v20$$x1380-2224$$y2013
000021501 8567_ $$uhttp://dx.doi.org/10.1007/s10934-012-9589-7
000021501 8564_ $$uhttps://juser.fz-juelich.de/record/21501/files/FZJ-21501.pdf$$yRestricted$$zPublished final document.
000021501 909CO $$ooai:juser.fz-juelich.de:21501$$pVDB
000021501 9131_ $$0G:(DE-Juel1)FUEK404$$bEnergie$$kP14$$lNukleare Sicherheitsforschung$$vNukleare Sicherheitsforschung$$x0
000021501 9132_ $$0G:(DE-HGF)POF3-169H$$1G:(DE-HGF)POF3-160$$2G:(DE-HGF)POF3-100$$aDE-HGF$$bForschungsbereich Energie$$lNukleare Entsorgung und Sicherheit sowie Strahlenforschung$$vAddenda$$x0
000021501 9141_ $$y2013
000021501 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000021501 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000021501 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000021501 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000021501 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000021501 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000021501 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000021501 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000021501 915__ $$0StatID:(DE-HGF)1020$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences
000021501 9201_ $$0I:(DE-Juel1)IEK-6-20101013$$gIEK$$kIEK-6$$lSicherheitsforschung und Reaktortechnik$$x0
000021501 970__ $$aVDB:(DE-Juel1)137504
000021501 980__ $$aVDB
000021501 980__ $$aConvertedRecord
000021501 980__ $$ajournal
000021501 980__ $$aI:(DE-Juel1)IEK-6-20101013
000021501 980__ $$aUNRESTRICTED
000021501 981__ $$aI:(DE-Juel1)IFN-2-20101013